2,692 Cigna Group $CI Shares Sold by MGO One Seven LLC

MGO One Seven LLC trimmed its position in shares of Cigna Group (NYSE:CI) by 47.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,020 shares of the health services provider’s stock after selling 2,692 shares during the period. MGO One Seven LLC’s holdings in Cigna Group were worth $821,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Osbon Capital Management LLC acquired a new stake in shares of Cigna Group during the 2nd quarter worth approximately $26,000. Cedar Mountain Advisors LLC raised its stake in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares in the last quarter. Johnson Financial Group Inc. bought a new position in Cigna Group in the second quarter worth $29,000. Fiduciary Financial Advisors bought a new position in Cigna Group in the second quarter worth $29,000. Finally, ANTIPODES PARTNERS Ltd acquired a new stake in Cigna Group during the second quarter worth $34,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of Cigna Group stock traded down $7.82 during mid-day trading on Friday, reaching $293.66. 2,427,984 shares of the stock were exchanged, compared to its average volume of 1,441,425. The company has a market cap of $77.60 billion, a price-to-earnings ratio of 12.96, a price-to-earnings-growth ratio of 1.00 and a beta of 0.25. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a 50-day simple moving average of $285.81 and a 200 day simple moving average of $282.17. Cigna Group has a fifty-two week low of $255.53 and a fifty-two week high of $318.05.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.52 by $0.46. The firm had revenue of $73.79 billion during the quarter, compared to the consensus estimate of $72.64 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s quarterly revenue was up 5.6% on a year-over-year basis. During the same period last year, the firm posted $7.83 EPS. On average, sell-side analysts predict that Cigna Group will post 30.52 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, December 3rd. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CI. Jefferies Financial Group lowered shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their price target for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Wall Street Zen downgraded shares of Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, October 31st. Royal Bank Of Canada reissued an “outperform” rating and issued a $337.00 target price on shares of Cigna Group in a research note on Thursday, October 1st. Piper Sandler restated an “overweight” rating on shares of Cigna Group in a research note on Friday, October 23rd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $340.00 price objective on shares of Cigna Group in a research note on Friday. Fourteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $335.70.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Trending Headlines about Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

Cigna Group Company Profile

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.